Sat, Dec 27, 2014, 9:49 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • larshansson18 larshansson18 Jul 9, 2010 2:39 PM Flag

    A short compairison: Valcade

    As you may already checked up your self the new member of the management team, Rita Kelley, have worked with Valcade at Millenium ( bought by Takeda). Have a look at slide 5 ( see link belov)for the development of sales for Valcade. Valcade is labeled for a sister disease to AML, named multiple myeloma. There are some 14 000 patients in the Valcade target patient group. The treatment was at this time in 2 lines.

    The figures are just for the US market. Do not look at the absolut figures but the surplus demand you can see filled the first two years. After that there is a linear increase. Look at the sales the first year. The drug was approved in the spring that year. More than double sales the next year.

    As stated before: Welcome to our management team Rita Kelley!

    http://www.takeda.com/pdf/usr/default/0804_01_e_29333_5.pdf

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IMNP
2.00+0.11(+5.82%)Dec 26 3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Prothena Corporation plc
NASDAQFri, Dec 26, 2014 4:00 PM EST
TherapeuticsMD, Inc.
AMEXFri, Dec 26, 2014 4:01 PM EST